Title : Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial.

Pub. Date : 2019 Apr

PMID : 30536182






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. Metformin erb-b2 receptor tyrosine kinase 2 Homo sapiens